|
Fang, Jianhua; Acheampong, Edward; Dave, Rajnish et al. (2005) The RNA helicase DDX1 is involved in restricted HIV-1 Rev function in human astrocytes. Virology 336:299-307
|
|
Nunnari, Giuseppe; Argyris, Elias; Fang, Jianhua et al. (2005) Inhibition of HIV-1 replication by caffeine and caffeine-related methylxanthines. Virology 335:177-84
|
|
Daniel, Rene; Marusich, Elena; Argyris, Elias et al. (2005) Caffeine inhibits human immunodeficiency virus type 1 transduction of nondividing cells. J Virol 79:2058-65
|
|
Kannangara, Saman; DeSimone, Joseph A; Pomerantz, Roger J (2005) Attenuation of HIV-1 infection by other microbial agents. J Infect Dis 192:1003-9
|
|
Di Mascio, Michele; Dornadula, Geethanjali; Zhang, Hui et al. (2003) In a subset of subjects on highly active antiretroviral therapy, human immunodeficiency virus type 1 RNA in plasma decays from 50 to <5 copies per milliliter, with a half-life of 6 months. J Virol 77:2271-5
|
|
Pomerantz, Roger J; Horn, David L (2003) Twenty years of therapy for HIV-1 infection. Nat Med 9:867-73
|
|
Kulkosky, Joseph; Sullivan, Julie; Xu, Yan et al. (2003) Genotypic alteration of HAART-persistent HIV-1 reservoirs in vivo. Virology 314:617-29
|
|
Kulkosky, Joseph; Pomerantz, Roger J (2002) Approaching eradication of highly active antiretroviral therapy-persistent human immunodeficiency virus type 1 reservoirs with immune activation therapy. Clin Infect Dis 35:1520-6
|
|
Pomerantz, Roger J (2002) HIV-1 reservoirs. Clin Lab Med 22:651-80, vi
|
|
Pomerantz, Roger J (2002) Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication. Clin Infect Dis 34:91-7
|
Showing the most recent 10 out of 17 publications
